COCP Stock, Cocrystal Pharma Inc. Information

Cocrystal is a clinical stage biotechnology company which develops novel medicines for use in the treatment of human viral diseases. Cocrystal has developed proprietary structure based drug design technology and antiviral nucleoside chemistry to create first in class and best in class antiviral drug candidates. Our focus is to pursue the development and commercialization of broad spectrum antiviral drug candidates that will transform the treatment and prophylaxis of hepatitis C, Influenza, and Norovirus. By concentrating our research and development efforts on viral replication inhibitors, we plan to leverage our infrastructure and expertise in these areas.